Human Genome Epidemiology Literature Finder
|
Records 1 - 13 (of 13 Records) |
| Query Trace: Thromboembolism and JAK2[original query] |
|---|
| Gain-of-function gene mutations and venous thromboembolism: distinct roles in different clinical settings. Journal of medical genetics 2007 Jun 44 (6): 412-6. Colaizzo Donatella, Amitrano Lucio, Iannaccone Luigi, Vergura Patrizia, Cappucci Filomena, Grandone Elvira, Guardascione Maria Anna, Margaglione Mauriz |
| Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms. British journal of haematology 2009 Mar 144 (6): 965-7. Za Tommaso, Fiorini Alessia, Rossi Elena, Ciminello Angela, Chiusolo Patrizia, Leone Giuseppe, De Stefano Valer |
| Is the JAK2 V617F mutation a hallmark for different forms of thrombosis? Acta haematologica 2010 124 (1): 49-56. Zerjavic Katja, Zagradisnik Boris, Stangler Herodez Spela, Lokar Lidija, Glaser Krasevac Marjana, Kokalj Vokac Nad |
| JAK2 mutations across a spectrum of venous thrombosis cases. American journal of clinical pathology 2010 Jul 134 (1): 82-5. Shetty Shrimati, Kulkarni Bipin, Pai Navin, Mukundan Preeti, Kasatkar Priyanka, Ghosh Kanjaks |
| Diagnostic value of JAK2 V617F somatic mutation for myeloproliferative cancer in 49 488 individuals from the general population. British journal of haematology 2013 Jan 160 (1): 70-9. Nielsen Camilla, Birgens Henrik S, Nordestgaard Børge G, Bojesen Stig |
| Genetic Risk Factors of Venous Thromboembolism in the East Algerian Population. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2015 Aug . Moussaoui S, Saussoy P, Ambroise J, Defour J P, Zouitene R, Sifi K, Abadi |
| The JAK2 V617F mutational status and allele burden may be related with the risk of venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms. Thrombosis research 2015 1 135 (2): 272-80. Borowczyk Martyna, Wojtaszewska Marzena, Lewandowski Krzysztof, Gil Lidia, Lewandowska Maria, Lehmann-Kopyd?owska Agata, Kroll-Balcerzak Renata, Balcerzak Andrzej, Iwo?a Ma?gorzata, Michalak Micha?, Komarnicki Mieczys? |
| Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population. Blood 2019 6 134 (5): 469-479. Cordua Sabrina, Kjaer Lasse, Skov Vibe, Pallisgaard Niels, Hasselbalch Hans C, Ellervik Christi |
| V617F-independent upregulation of JAK2 gene expression in patients with inflammatory bowel disease. Journal of cellular biochemistry 2019 May . Asadzadeh-Aghdaei Hamid, Mashayekhi Kazem, Koushki Khadijeh, Azimzadeh Pedram, Rostami-Nejad Mohammad, Amani Davar, Chaleshi Vahid, Haftcheshmeh Saeed Mohammadian, Sahebkar Amirhossein, Zali Mohammad Re |
| Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations. JACC. CardioOncology 2022 Mar 4 (1): 38-49. Calvillo-Argüelles Oscar, Schoffel Alice, Capo-Chichi José-Mario, Abdel-Qadir Husam, Schuh Andre, Carrillo-Estrada Montserrat, Liu Shiying, Gupta Vikas, Schimmer Aaron D, Yee Karen, Shlush Liran I, Natarajan Pradeep, Thavendiranathan Paaladine |
| Arterial and Venous Thromboembolic Complications in 832 Patients with BCR-ABL-Negative Myeloproliferative Neoplasms. Hamostaseologie 2023 10 . Kai Wille, Eva Deventer, Parvis Sadjadian, Tatjana Becker, Vera Kolatzki, Karlo Hünerbein, Raphael Meixner, Marina Jiménez-Muñoz, Christiane Fuchs, Martin Griesshamm |
| JAK2-mutant Clonal Hematopoiesis is Associated with Venous Thromboembolism. Blood 2024 8 . Rebecca L Zon, Aswin Sekar, Katharine Clapham, Ohad Oren, Abhishek Niroula, Alexander G Bick, Christopher J Gibson, Gabriel K Griffin, Md Mesbah Uddin, Donna S Neuberg, Pradeep Natarajan, Benjamin L Ebe |
| [Analysis of risk factors for venous thromboembolism in patients with polycythemia vera and establishment of a prediction model]. Zhonghua yi xue za zhi 2024 7 104 (25): 2336-2341. J Y Ma, Y H Zhang, G S Teng, C X Du, H Q Zhang, Y Wang, Y Q Li, Y F Duan, Y Zhou, Z H Shao, J B |
- Page last reviewed:Feb 1, 2024
- Content source: